Gland Pharma share price: key levels for April 2026

What changed in the latest session

GLAND PHARMA LIMITED was last reported at ₹1,751.1, up ₹26.79 from the previous close in the latest trading session mentioned in the data. The day’s range was ₹1,741.20 to ₹1,782.80, showing a relatively narrow intraday swing. The same dataset also lists a one-year return of 20.89% and a one-month return of 6.00%.

Separately, another snapshot in the provided text highlights a different close and context for 13 Apr, 2026, where the stock is shown at ₹1,724.30, down ₹17.60 (-1.01%). These different prints appear to be from different timestamps or market feeds, so the key is to focus on the ranges and levels that repeat consistently across the text.

13 April 2026 snapshot: price, range and volume

As per the 13 Apr, 2026 NSE/BSE snapshot in the text, Gland Pharma opened at ₹1,701.10 and the previous close was ₹1,741.90. During that session, the stock traded between ₹1,693.30 (low) and ₹1,749.00 (high), with an average price for the day reported as ₹1,721.15 in one place and ₹1,727.27 in another.

The reported traded volume was 53,303. The same page categorised the intraday trend as Downtrend. A stock score of 66/100 was also shown, alongside a label indicating “Superior Financial Strength, Average Growth Trend Stock at Reasonable Valuations.”

Where the 52-week range sits

Across the text, the 52-week levels are repeated clearly for NSE: ₹2,131.00 (high) and ₹1,382.30 (low). For BSE, the 52-week high and low are shown as ₹2,130.00 and ₹1,382.10. Another section also mentions a 52-week low of ₹1,277.80 and high of ₹2,131.00, indicating that different trackers may be using different lookback windows or reference dates.

One stated positioning metric says the price was 19.08% away from the 52-week high at the time of that snapshot. Another line elsewhere notes a current price of ₹2,018.3 being -9.12% from a stated 52-week high and 57.95% up from a stated 52-week low. These variations again reinforce that multiple feeds are embedded in the supplied text.

Returns: strong 1-year, weaker 6-month trend

The data includes multiple return sets:

• Over 1 month: +6.00% (also shown as +6.01%)
• Over 6 months: -10.6% (also shown as -10.59%)
• Over 1 year: +20.89% (also shown as +23.72%)
• A return calculator section also lists 3-year: +36.74% and 5-year: -33.22%

Taken together, the short-term tone is positive over one month, the medium-term (six months) is negative, and the longer one-year view is positive as per the trackers cited.

Technical picture: mixed to neutral signals

The technical indicators table in the provided text flags several readings as neutral, with a few directional tags:

• RSI(14): 52.23 (Neutral)
• ATR(14): 55.09 (Volatile)
• STOCH(9,6): 63.21 (Neutral)
• STOCH RSI(14): 90.69 (Overbought)
• MACD(12,26): 11.76 (Bullish)
• ADX(14): 19.13 (Weak Trend)

Moving averages are presented in two places with slightly different values. One set lists 20D: ₹1,708.38, 50D: ₹1,726.17, 100D: ₹1,751.60, 200D: ₹1,766.45. Another line separately states 50 DMA: ₹1,757.72 and 200 DMA: ₹1,832.71. The more detailed EMA/SMA block also notes 9 bearish and 7 bullish moving averages.

Market depth: what the order book showed

A BSE market depth table dated 13 Apr 2026 shows multiple buy and sell levels. On the buy side, quantities were visible at ₹1,713.30, ₹1,707.00, ₹1,705.10, ₹1,705.00, and ₹1,704.50. On the sell side, offers appeared at ₹1,739.45, ₹1,774.00, ₹1,810.00, ₹1,818.00, and ₹1,850.00.

Order-book snapshots change quickly, but the presence of visible offers above ₹1,739 and bids clustered around ₹1,704 to ₹1,713 frames the near-term liquidity levels recorded in that session.

Valuation and company snapshot in the feed

In the “GLAND Share Price” block, the dataset lists:

• Market cap: ₹28,409 Cr
• PE ratio: 33.80
• ROCE: 11.44%

A separate historical broker-style snippet (dated Nov 11, 2025) lists PE at 38.55, PB at 3.19, and market cap at ₹30,499.63 Cr, highlighting that these metrics can vary over time and by source.

Shareholding, strengths and stated risks

The text notes that promoter holding remained unchanged at 51.83% in the Dec 2025 quarter. It also flags a weakness that FII/FPI decreased their shareholding last quarter. Another risk label in the same block states “Below 200 DMA.” On the positives, it highlights “Good quarterly growth in the recent results.”

Sector headlines that influenced sentiment

The provided feed includes multiple headlines linking pharma stock moves to US tariff-related announcements attributed to US President Donald Trump. One headline says Indian pharma stocks “tumble” after a 100% tariff on branded drugs is announced, and another notes Gland Pharma slipping 4.03% to ₹1,892.50 in that context. Another headline in the text says the stock rallied 9.76% to ₹1,685 on April 3 after clarification that pharmaceuticals would be excluded from a 26% reciprocal tariff.

These references indicate that macro headlines and policy signals have been a driver of short-term volatility in pharma counters in the dataset.

Key numbers at a glance

What investors typically track from here

From the numbers in the feed, traders will likely keep an eye on the repeatedly cited bands: the ₹1,693 to ₹1,749 area (from 13 Apr) and the ₹1,741 to ₹1,783 zone (from the latest session line). The moving averages shown around the ₹1,726 to ₹1,766 region (in one set) also place the stock close to commonly watched trend gauges.

Future direction in the dataset is framed mainly through technical tags like “Downtrend,” “Weak Trend,” and a mix of “Bullish” (MACD) and “Neutral” (RSI) readings, rather than any new financial guidance or corporate announcement in the supplied text.

Conclusion

Gland Pharma’s mid-April 2026 tape in the provided data shows a stock trading within defined intraday ranges, with positive 1-month returns, negative 6-month performance, and positive 1-year returns depending on the tracker. The 52-week band around ₹1,382 to ₹2,131 remains the primary longer-term reference range, while near-term attention stays on the moving-average cluster and daily support-resistance levels visible in the order book and day ranges.